nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—adrenal gland cancer	0.972	1	CbGaD
Phenylbutazone—PTGIS—Nicotinamide salvaging—PTGS2—adrenal gland cancer	0.00334	0.149	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—adrenal gland cancer	0.00178	0.0791	CbGpPWpGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.00147	0.0652	CbGpPWpGaD
Phenylbutazone—PTGIS—Endogenous sterols—POMC—adrenal gland cancer	0.00124	0.055	CbGpPWpGaD
Phenylbutazone—Oxaprozin—PTGS2—adrenal gland cancer	0.0012	0.238	CrCbGaD
Phenylbutazone—Protriptyline—ABCB1—adrenal gland cancer	0.00103	0.206	CrCbGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.000954	0.0424	CbGpPWpGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—adrenal gland cancer	0.000945	0.188	CrCbGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.000798	0.0355	CbGpPWpGaD
Phenylbutazone—PTGIS—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000574	0.0255	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00053	0.0236	CbGpPWpGaD
Phenylbutazone—Fentanyl—ABCB1—adrenal gland cancer	0.000515	0.103	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—adrenal gland cancer	0.000512	0.102	CrCbGaD
Phenylbutazone—Phenytoin—ABCB1—adrenal gland cancer	0.000467	0.093	CrCbGaD
Phenylbutazone—PTGIS—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000466	0.0207	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—PRKACA—adrenal gland cancer	0.00046	0.0204	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.000451	0.0201	CbGpPWpGaD
Phenylbutazone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000447	0.0199	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.000353	0.0157	CbGpPWpGaD
Phenylbutazone—Methadone—ABCB1—adrenal gland cancer	0.000353	0.0703	CrCbGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.00034	0.0151	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—RB1—adrenal gland cancer	0.0003	0.0133	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.000293	0.013	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—POMC—adrenal gland cancer	0.000247	0.011	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.000245	0.0109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000245	0.0109	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000239	0.0106	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SH3KBP1—adrenal gland cancer	0.000225	0.00998	CbGpPWpGaD
Phenylbutazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000224	0.00994	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SDHB—adrenal gland cancer	0.000221	0.00983	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—CTNNB1—adrenal gland cancer	0.000221	0.00982	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000213	0.00947	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ZNRF3—adrenal gland cancer	0.000211	0.00938	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000201	0.00894	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000187	0.00831	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000174	0.00774	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000168	0.00748	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000163	0.00724	CbGpPWpGaD
Phenylbutazone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000148	0.00656	CbGpPWpGaD
Phenylbutazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000143	0.00636	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SDHD—adrenal gland cancer	0.000143	0.00633	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—RRM1—adrenal gland cancer	0.000143	0.00633	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000141	0.00625	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SPRY2—adrenal gland cancer	0.000132	0.00588	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000127	0.00564	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MEN1—adrenal gland cancer	0.000121	0.00539	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000116	0.00513	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—MED12—adrenal gland cancer	0.000106	0.00472	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000104	0.00461	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000102	0.00455	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	9.88e-05	0.00439	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	9.8e-05	0.00436	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.5e-05	0.00422	CbGpPWpGaD
Phenylbutazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.28e-05	0.00413	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PRKACA—adrenal gland cancer	9.26e-05	0.00411	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	9.14e-05	0.00406	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	8.57e-05	0.00381	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	8.09e-05	0.0036	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	8e-05	0.00356	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	7.92e-05	0.00352	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.85e-05	0.00349	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDC42—adrenal gland cancer	7.85e-05	0.00349	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PRKACA—adrenal gland cancer	7.75e-05	0.00345	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—POMC—adrenal gland cancer	7.6e-05	0.00338	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.58e-05	0.00337	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.53e-05	0.00335	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	7.53e-05	0.00334	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.33e-05	0.00326	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SDHB—adrenal gland cancer	6.8e-05	0.00302	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TERT—adrenal gland cancer	6.3e-05	0.0028	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.29e-05	0.00279	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GNAS—adrenal gland cancer	6.28e-05	0.00279	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ABCB1—adrenal gland cancer	6.17e-05	0.00274	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.12e-05	0.00272	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.1e-05	0.00271	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.02e-05	0.00268	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.99e-05	0.00266	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.82e-05	0.00259	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BAD—adrenal gland cancer	5.48e-05	0.00244	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SH3KBP1—adrenal gland cancer	5.48e-05	0.00244	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SDHB—adrenal gland cancer	5.4e-05	0.0024	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.35e-05	0.00238	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ZNRF3—adrenal gland cancer	5.15e-05	0.00229	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.09e-05	0.00226	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5e-05	0.00222	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BRAF—adrenal gland cancer	4.99e-05	0.00222	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.96e-05	0.00221	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	4.61e-05	0.00205	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SDHD—adrenal gland cancer	4.38e-05	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—RRM1—adrenal gland cancer	4.38e-05	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.25e-05	0.00189	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—POMC—adrenal gland cancer	4.23e-05	0.00188	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—adrenal gland cancer	4.03e-05	0.00179	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	4e-05	0.00178	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.96e-05	0.00176	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	3.87e-05	0.00172	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.86e-05	0.00171	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—adrenal gland cancer	3.61e-05	0.0016	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SDHB—adrenal gland cancer	3.57e-05	0.00159	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—RRM1—adrenal gland cancer	3.48e-05	0.00155	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SDHD—adrenal gland cancer	3.48e-05	0.00155	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—adrenal gland cancer	3.37e-05	0.0015	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MED12—adrenal gland cancer	3.27e-05	0.00145	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SPRY2—adrenal gland cancer	3.23e-05	0.00144	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.14e-05	0.00139	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MEN1—adrenal gland cancer	2.96e-05	0.00132	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.92e-05	0.0013	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—adrenal gland cancer	2.86e-05	0.00127	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.81e-05	0.00125	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.64e-05	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.64e-05	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MED12—adrenal gland cancer	2.59e-05	0.00115	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PRKACA—adrenal gland cancer	2.38e-05	0.00106	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.36e-05	0.00105	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.33e-05	0.00104	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.32e-05	0.00103	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2.3e-05	0.00102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2.3e-05	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKACA—adrenal gland cancer	2.26e-05	0.001	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GNAS—adrenal gland cancer	1.93e-05	0.000858	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDC42—adrenal gland cancer	1.92e-05	0.000852	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—adrenal gland cancer	1.9e-05	0.000842	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PRKACA—adrenal gland cancer	1.89e-05	0.000841	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.72e-05	0.000763	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TERT—adrenal gland cancer	1.54e-05	0.000683	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.53e-05	0.000682	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GNAS—adrenal gland cancer	1.53e-05	0.000681	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.52e-05	0.000675	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.52e-05	0.000675	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—adrenal gland cancer	1.5e-05	0.000669	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BAD—adrenal gland cancer	1.34e-05	0.000594	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POMC—adrenal gland cancer	1.3e-05	0.000578	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.25e-05	0.000557	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.22e-05	0.000544	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BRAF—adrenal gland cancer	1.22e-05	0.000541	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.13e-05	0.000503	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—adrenal gland cancer	1.04e-05	0.000461	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POMC—adrenal gland cancer	1.03e-05	0.000459	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.02e-05	0.000451	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	9.96e-06	0.000443	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—adrenal gland cancer	8.8e-06	0.000391	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.26e-06	0.000367	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—adrenal gland cancer	6.97e-06	0.00031	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POMC—adrenal gland cancer	6.84e-06	0.000304	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	6.7e-06	0.000298	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.57e-06	0.000292	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	5.45e-06	0.000242	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.51e-06	0.0002	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.6e-06	0.00016	CbGpPWpGaD
